Skip to main content

JPMORGAN CHASE & CO

Position in GH — Guardant Health, Inc.

CIK 19617 NEW YORK, NY

Position in GH

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$82,379,669
+$54,269,912 QoQ
Shares Held
549,088
+80.4% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 594 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $14,872,166,546 across 37 Diagnostics & Research names. GH ranks #13 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $82,379,669 549,088
2026-03-31 $28,109,757 304,317
2025-12-31 $27,683,920 271,039
2025-09-30 $30,853,933 493,821
2025-06-30 $10,059,434 193,302
2025-03-31 $7,507,098 176,223
2024-12-31 $20,686,193 677,126
2024-09-30 $4,577,534 199,544
2024-06-30 $12,400,634 429,385
2024-03-31 $3,305,977 160,251
2023-12-31 $13,060,089 482,813
2023-09-30 $12,559,144 423,723
2023-06-30 $24,628,606 687,950
2023-03-31 $15,074,189 643,097
2022-12-31 $5,033,521 185,056
2022-09-30 $53,706,457 997,705
2022-06-30 $7,049,452 174,751
2022-03-31 $12,589,834 190,064
2021-12-31 $24,171,331 241,665
2021-09-30 $14,574,038 116,583
2021-06-30 $47,569,487 383,038
2021-03-31 $56,529,802 370,323
2020-12-31 $74,768,051 580,137
2020-09-30 $25,121,658 224,742
2020-06-30 $27,529,187 339,322
2020-03-31 $19,420,135 279,025